Market Overview:
The global personalized medicine (PM) solution market is expected to grow at a CAGR of 16.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for personalized therapies and diagnostics, rising prevalence of chronic diseases, and growing investments by pharmaceutical companies in R&D for developing novel personalized therapies. Based on type, the global PM solution market is segmented into personalization diagnostics, personalization therapies, and personalized nutrition & wellness. The personalization diagnostics segment is further divided into pharmacogenomics testing, exome sequencing & genotyping services, tumor profiling services, and other diagnostic services. The pharmacogenomics testing segment accounted for the largest share of the global PM solution market in 2017 owing to its growing demand for identifying drug-gene interactions that can lead to adverse effects or therapeutic failures.
Product Definition:
PM solution is a technology that allows customization of treatments for patients based on their individual genetic makeup.
1) It can help to target therapies to the individuals who are most likely to benefit from them.
2) It can help to avoid or minimize adverse effects of treatment.
3) It can improve patient outcomes and quality of life.
Personalized Diagnostics:
Personalized diagnostics (PDx) is the new kid on the block in healthcare industry. It's a combination of laboratory tests and diagnostic devices that are designed to meet specific needs of patients. These tests can be used with other diagnostic tools to provide more complete picture of disease state for improved patient care, which is expected to boost demand over the forecast period.
Personalized medicine (PM) solution helps healthcare providers.
Personalized Therapies:
Personalized therapies are the medical procedures that are performed on an individual basis, based on their genetic profile. It is a growing field within medicine and science which helps in treating patients with specific treatments and medicines. The main aim of personalized therapies is to treat each patient as an individual instead of treating the whole population group at once. Personalized Therapies (PT) help in finding out genetic factors that may cause diseases, along with other factors that trigger or aggravate them.
Application Insights:
Oncology accounted for the largest share in 2015 owing to increasing prevalence of cancer and rising number of PM-targeted therapies. The growing adoption of these solutions in oncology due to various factors such as availability of advanced diagnostics, rising incidences, and increasing survival rates is anticipated to boost demand over the forecast period.
The neurosciences segment is expected to register a significant growth rate over the forecast period owing to an increase in incidence rates for Alzheimer¢â‚¬â„¢s disease, Parkinson's disease, multiple sclerosis and others which are associated with aging processes. Moreover, an increase in research & development activities pertaining towards personalized medicine for treatment of neurological disorders is further estimated to propel market growth during future years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies, and favorable reimbursement policies & regulatory reforms. The U.S., in particular, is a major revenue contributor owing to its well-developed healthcare infrastructure and strong commercialization of personalized medicine solutions by companies based there.
Asia Pacific is expected to witness lucrative growth over the forecast period due to factors such as rising disposable income coupled with growing awareness about early diagnosis and effective treatment for various diseases prevalent in this region. Moreover, an increase in investments by international players for expansion into untapped areas will boost regional growth during the forecast period (2018-2030). For instance, Novartis invested USD X million for a 10% stake acquisition by GSK plc., which is anticipated to propel Novartis' cancer care portfolio across Asia Pacific region over next few years (Novartis 2016).
Growth Factors:
- Increasing demand for precision medicine to target specific diseases and improve patient outcomes
- Advances in technology and data analytics that enable more personalized diagnosis and treatment planning
- Growing number of PM clinical trials to assess the safety and efficacy of novel therapies
- Rising prevalence of chronic diseases that require lifelong management
- Increased focus on value-based care as a way to contain healthcare costs
Scope Of The Report
Report Attributes
Report Details
Report Title
Personalized Medicine (PM) Solution Market Research Report
By Type
Personalized Diagnostics, Personalized Therapies, Personalized Nutrition & Wellness
By Application
Oncology, Neurosciences, Immunology, Respiratory, Others
By Companies
2bPrecise, OneOme, TIGAR Health- IR2Dx, Kailos Genetics, Syapse Inc, Karius, Astarte Medical, Fabric Genomics, INC., Orion Health, 2B Precise, Fabric Genomics, Pfizer, Gene 42, IBM Watson Health, Philips Healthcare, Medtronic, Nanthealth, Navican, N-of-One, PierianDx, Sunquest Information System, Tempus, Novartis, Translational Software, Biocrates Life Sciences AG, Nanostring Technologies, Thermo Fisher Scientific, Quest Diagnostics Incorporated
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
219
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Personalized Medicine (PM) Solution Market Report Segments:
The global Personalized Medicine (PM) Solution market is segmented on the basis of:
Types
Personalized Diagnostics, Personalized Therapies, Personalized Nutrition & Wellness
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Neurosciences, Immunology, Respiratory, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 2bPrecise
- OneOme
- TIGAR Health- IR2Dx
- Kailos Genetics
- Syapse Inc
- Karius
- Astarte Medical
- Fabric Genomics, INC.
- Orion Health
- 2B Precise
- Fabric Genomics
- Pfizer
- Gene 42
- IBM Watson Health
- Philips Healthcare
- Medtronic
- Nanthealth
- Navican
- N-of-One
- PierianDx
- Sunquest Information System
- Tempus
- Novartis
- Translational Software
- Biocrates Life Sciences AG
- Nanostring Technologies
- Thermo Fisher Scientific
- Quest Diagnostics Incorporated
Highlights of The Personalized Medicine (PM) Solution Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Personalized Diagnostics
- Personalized Therapies
- Personalized Nutrition & Wellness
- By Application:
- Oncology
- Neurosciences
- Immunology
- Respiratory
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Personalized Medicine (PM) Solution Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Personalized medicine (PM) is a healthcare delivery model that tailors treatments and interventions to the specific needs of an individual patient. PM can be used in a variety of settings, including hospitals, clinics, and pharmacies.
Some of the key players operating in the personalized medicine (pm) solution market are 2bPrecise, OneOme, TIGAR Health- IR2Dx, Kailos Genetics, Syapse Inc, Karius, Astarte Medical, Fabric Genomics, INC., Orion Health, 2B Precise, Fabric Genomics, Pfizer, Gene 42, IBM Watson Health, Philips Healthcare, Medtronic, Nanthealth, Navican, N-of-One, PierianDx, Sunquest Information System, Tempus, Novartis, Translational Software, Biocrates Life Sciences AG, Nanostring Technologies, Thermo Fisher Scientific, Quest Diagnostics Incorporated.
The personalized medicine (pm) solution market is expected to grow at a compound annual growth rate of 16.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Personalized Medicine (PM) Solution Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Personalized Medicine (PM) Solution Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Personalized Medicine (PM) Solution Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Personalized Medicine (PM) Solution Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Personalized Medicine (PM) Solution Market Size & Forecast, 2018-2028 4.5.1 Personalized Medicine (PM) Solution Market Size and Y-o-Y Growth 4.5.2 Personalized Medicine (PM) Solution Market Absolute $ Opportunity
Chapter 5 Global Personalized Medicine (PM) Solution Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Personalized Medicine (PM) Solution Market Size Forecast by Type
5.2.1 Personalized Diagnostics
5.2.2 Personalized Therapies
5.2.3 Personalized Nutrition & Wellness
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Personalized Medicine (PM) Solution Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Personalized Medicine (PM) Solution Market Size Forecast by Applications
6.2.1 Oncology
6.2.2 Neurosciences
6.2.3 Immunology
6.2.4 Respiratory
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Personalized Medicine (PM) Solution Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Personalized Medicine (PM) Solution Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Personalized Medicine (PM) Solution Analysis and Forecast
9.1 Introduction
9.2 North America Personalized Medicine (PM) Solution Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Personalized Medicine (PM) Solution Market Size Forecast by Type
9.6.1 Personalized Diagnostics
9.6.2 Personalized Therapies
9.6.3 Personalized Nutrition & Wellness
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Personalized Medicine (PM) Solution Market Size Forecast by Applications
9.10.1 Oncology
9.10.2 Neurosciences
9.10.3 Immunology
9.10.4 Respiratory
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Personalized Medicine (PM) Solution Analysis and Forecast
10.1 Introduction
10.2 Europe Personalized Medicine (PM) Solution Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Personalized Medicine (PM) Solution Market Size Forecast by Type
10.6.1 Personalized Diagnostics
10.6.2 Personalized Therapies
10.6.3 Personalized Nutrition & Wellness
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Personalized Medicine (PM) Solution Market Size Forecast by Applications
10.10.1 Oncology
10.10.2 Neurosciences
10.10.3 Immunology
10.10.4 Respiratory
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Personalized Medicine (PM) Solution Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Personalized Medicine (PM) Solution Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Personalized Medicine (PM) Solution Market Size Forecast by Type
11.6.1 Personalized Diagnostics
11.6.2 Personalized Therapies
11.6.3 Personalized Nutrition & Wellness
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Personalized Medicine (PM) Solution Market Size Forecast by Applications
11.10.1 Oncology
11.10.2 Neurosciences
11.10.3 Immunology
11.10.4 Respiratory
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Personalized Medicine (PM) Solution Analysis and Forecast
12.1 Introduction
12.2 Latin America Personalized Medicine (PM) Solution Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Personalized Medicine (PM) Solution Market Size Forecast by Type
12.6.1 Personalized Diagnostics
12.6.2 Personalized Therapies
12.6.3 Personalized Nutrition & Wellness
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Personalized Medicine (PM) Solution Market Size Forecast by Applications
12.10.1 Oncology
12.10.2 Neurosciences
12.10.3 Immunology
12.10.4 Respiratory
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Personalized Medicine (PM) Solution Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Personalized Medicine (PM) Solution Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Personalized Medicine (PM) Solution Market Size Forecast by Type
13.6.1 Personalized Diagnostics
13.6.2 Personalized Therapies
13.6.3 Personalized Nutrition & Wellness
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Personalized Medicine (PM) Solution Market Size Forecast by Applications
13.10.1 Oncology
13.10.2 Neurosciences
13.10.3 Immunology
13.10.4 Respiratory
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Personalized Medicine (PM) Solution Market: Competitive Dashboard
14.2 Global Personalized Medicine (PM) Solution Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 2bPrecise
14.3.2 OneOme
14.3.3 TIGAR Health- IR2Dx
14.3.4 Kailos Genetics
14.3.5 Syapse Inc
14.3.6 Karius
14.3.7 Astarte Medical
14.3.8 Fabric Genomics, INC.
14.3.9 Orion Health
14.3.10 2B Precise
14.3.11 Fabric Genomics
14.3.12 Pfizer
14.3.13 Gene 42
14.3.14 IBM Watson Health
14.3.15 Philips Healthcare
14.3.16 Medtronic
14.3.17 Nanthealth
14.3.18 Navican
14.3.19 N-of-One
14.3.20 PierianDx
14.3.21 Sunquest Information System
14.3.22 Tempus
14.3.23 Novartis
14.3.24 Translational Software
14.3.25 Biocrates Life Sciences AG
14.3.26 Nanostring Technologies
14.3.27 Thermo Fisher Scientific
14.3.28 Quest Diagnostics Incorporated